-
1
-
-
0042195833
-
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
-
10.1001/jama.290.7.891 12928465 10.1001/jama.290.7.891
-
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW (2003) Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290(7):891-897. doi: 10.1001/jama.290.7.891
-
(2003)
JAMA
, vol.290
, Issue.7
, pp. 891-897
-
-
Greenland, P.1
Knoll, M.D.2
Stamler, J.3
Neaton, J.D.4
Dyer, A.R.5
Garside, D.B.6
Wilson, P.W.7
-
2
-
-
0042697063
-
Prevalence of conventional risk factors in patients with coronary heart disease
-
10.1001/jama.290.7.898 12928466 10.1001/jama.290.7.898
-
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ (2003) Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290(7):898-904. doi: 10.1001/jama.290.7.898
-
(2003)
JAMA
, vol.290
, Issue.7
, pp. 898-904
-
-
Khot, U.N.1
Khot, M.B.2
Bajzer, C.T.3
Sapp, S.K.4
Ohman, E.M.5
Brener, S.J.6
Ellis, S.G.7
Lincoff, A.M.8
Topol, E.J.9
-
3
-
-
17644412023
-
Inflammation, atherosclerosis, and coronary artery disease
-
10.1056/NEJMra043430 15843671 10.1056/NEJMra043430 1:CAS:528: DC%2BD2MXjsFCltrc%3D
-
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685-1695. doi: 10.1056/NEJMra043430
-
(2005)
N Engl J Med
, vol.352
, Issue.16
, pp. 1685-1695
-
-
Hansson, G.K.1
-
4
-
-
3042748693
-
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events
-
10.1161/01.CIR.0000133444.17867.56
-
Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL (2004) Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109(25 Suppl 1):6-19. doi: 10.1161/01.CIR.0000133444.17867. 56
-
(2004)
Circulation
, vol.109
, Issue.25 SUPPL. 1
, pp. 6-19
-
-
Ridker, P.M.1
Brown, N.J.2
Vaughan, D.E.3
Harrison, D.G.4
Mehta, J.L.5
-
5
-
-
33845709506
-
Multiple biomarkers for the prediction of first major cardiovascular events and death
-
10.1056/NEJMoa055373 17182988 10.1056/NEJMoa055373 1:CAS:528: DC%2BD28XhtlGhtLvJ
-
Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS (2006) Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 355(25):2631-2639. doi: 10.1056/NEJMoa055373
-
(2006)
N Engl J Med
, vol.355
, Issue.25
, pp. 2631-2639
-
-
Wang, T.J.1
Gona, P.2
Larson, M.G.3
Tofler, G.H.4
Levy, D.5
Newton-Cheh, C.6
Jacques, P.F.7
Rifai, N.8
Selhub, J.9
Robins, S.J.10
Benjamin, E.J.11
D'Agostino, R.B.12
Vasan, R.S.13
-
6
-
-
67649992452
-
Novel and conventional biomarkers for prediction of incident cardiovascular events in the community
-
10.1001/jama.2009.943 19567439 10.1001/jama.2009.943 1:CAS:528: DC%2BD1MXotFKns7o%3D
-
Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler NG, Bergmann A, Pencina MJ, Wang TJ (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302(1):49-57. doi: 10.1001/jama.2009.943
-
(2009)
JAMA
, vol.302
, Issue.1
, pp. 49-57
-
-
Melander, O.1
Newton-Cheh, C.2
Almgren, P.3
Hedblad, B.4
Berglund, G.5
Engstrom, G.6
Persson, M.7
Smith, J.G.8
Magnusson, M.9
Christensson, A.10
Struck, J.11
Morgenthaler, N.G.12
Bergmann, A.13
Pencina, M.J.14
Wang, T.J.15
-
7
-
-
77953356167
-
Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project
-
10.1161/CIRCULATIONAHA.109.901413 20497981 10.1161/CIRCULATIONAHA.109. 901413
-
Blankenberg S, Zeller T, Saarela O, Havulinna AS, Kee F, Tunstall-Pedoe H, Kuulasmaa K, Yarnell J, Schnabel RB, Wild PS, Munzel TF, Lackner KJ, Tiret L, Evans A, Salomaa V (2010) Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 121(22):2388-2397. doi: 10.1161/CIRCULATIONAHA.109.901413
-
(2010)
Circulation
, vol.121
, Issue.22
, pp. 2388-2397
-
-
Blankenberg, S.1
Zeller, T.2
Saarela, O.3
Havulinna, A.S.4
Kee, F.5
Tunstall-Pedoe, H.6
Kuulasmaa, K.7
Yarnell, J.8
Schnabel, R.B.9
Wild, P.S.10
Munzel, T.F.11
Lackner, K.J.12
Tiret, L.13
Evans, A.14
Salomaa, V.15
-
8
-
-
33846996345
-
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds risk score
-
10.1001/jama.297.6.611 17299196 10.1001/jama.297.6.611 1:CAS:528:DC%2BD2sXhslCqtLk%3D
-
Ridker PM, Buring JE, Rifai N, Cook NR (2007) Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. JAMA 297(6):611-619. doi: 10.1001/jama.297.6.611
-
(2007)
JAMA
, vol.297
, Issue.6
, pp. 611-619
-
-
Ridker, P.M.1
Buring, J.E.2
Rifai, N.3
Cook, N.R.4
-
9
-
-
43549117072
-
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
-
10.1056/NEJMoa0707064 18480203 10.1056/NEJMoa0707064 1:CAS:528: DC%2BD1cXlvFCrsrw%3D
-
Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Venge P, Arnlov J (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358(20):2107-2116. doi: 10.1056/NEJMoa0707064
-
(2008)
N Engl J Med
, vol.358
, Issue.20
, pp. 2107-2116
-
-
Zethelius, B.1
Berglund, L.2
Sundstrom, J.3
Ingelsson, E.4
Basu, S.5
Larsson, A.6
Venge, P.7
Arnlov, J.8
-
10
-
-
44249118880
-
Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events
-
10.1007/s00392-007-0629-2 18193374 10.1007/s00392-007-0629-2 1:CAS:528:DC%2BD1cXmvVCltb0%3D
-
Simon T, Becker R, Voss F, Bikou O, Hauck M, Licka M, Katus HA, Bauer A (2008) Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events. Clin Res Cardiol 97(5):306-309. doi: 10.1007/s00392-007-0629-2
-
(2008)
Clin Res Cardiol
, vol.97
, Issue.5
, pp. 306-309
-
-
Simon, T.1
Becker, R.2
Voss, F.3
Bikou, O.4
Hauck, M.5
Licka, M.6
Katus, H.A.7
Bauer, A.8
-
11
-
-
38549162278
-
Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure
-
10.1016/j.amjcard.2007.08.038 18237602 10.1016/j.amjcard.2007.08.038 1:CAS:528:DC%2BD1cXhsVSmsL8%3D
-
Tang WH, Shrestha K, Van Lente F, Troughton RW, Martin MG, Borowski AG, Jasper S, Klein AL (2008) Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure. Am J Cardiol 101(3):370-373. doi: 10.1016/j.amjcard.2007.08.038
-
(2008)
Am J Cardiol
, vol.101
, Issue.3
, pp. 370-373
-
-
Tang, W.H.1
Shrestha, K.2
Van Lente, F.3
Troughton, R.W.4
Martin, M.G.5
Borowski, A.G.6
Jasper, S.7
Klein, A.L.8
-
12
-
-
33646511582
-
Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes
-
10.1007/s00392-006-0375-x 16598393 10.1007/s00392-006-0375-x 1:CAS:528:DC%2BD28XmtFOqsbo%3D
-
Weber M, Kleine C, Keil E, Rau M, Berkowitsch A, Elsaesser A, Mitrovic V, Hamm C (2006) Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes. Clin Res Cardiol 95(5):270-280. doi: 10.1007/s00392-006-0375-x
-
(2006)
Clin Res Cardiol
, vol.95
, Issue.5
, pp. 270-280
-
-
Weber, M.1
Kleine, C.2
Keil, E.3
Rau, M.4
Berkowitsch, A.5
Elsaesser, A.6
Mitrovic, V.7
Hamm, C.8
-
13
-
-
78649672497
-
Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction
-
10.1007/s00392-010-0193-z 20596713 10.1007/s00392-010-0193-z 1:CAS:528:DC%2BC3cXhsVynu7%2FI
-
Meisinger C, Heier M, von Scheidt W, Kuch B (2010) Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction. Clin Res Cardiol 99(12):817-823. doi: 10.1007/s00392-010-0193-z
-
(2010)
Clin Res Cardiol
, vol.99
, Issue.12
, pp. 817-823
-
-
Meisinger, C.1
Heier, M.2
Von Scheidt, W.3
Kuch, B.4
-
14
-
-
77954659815
-
Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement
-
10.1007/s00392-010-0118-x 20140438 10.1007/s00392-010-0118-x 1:CAS:528:DC%2BC3cXlt1Wqsrw%3D
-
Pfister R, Wahlers T, Baer FM, Scherner M, Strauch J, Erdmann E (2010) Utility of NT-pro-BNP in patients undergoing transapical aortic valve replacement. Clin Res Cardiol 99(5):301-307. doi: 10.1007/s00392-010-0118-x
-
(2010)
Clin Res Cardiol
, vol.99
, Issue.5
, pp. 301-307
-
-
Pfister, R.1
Wahlers, T.2
Baer, F.M.3
Scherner, M.4
Strauch, J.5
Erdmann, E.6
-
15
-
-
21044445439
-
Cardiovascular risk factors in primary care: Methods and baseline prevalence rates - The DETECT program
-
10.1185/030079905X38187 15899112 10.1185/030079905X38187
-
Wittchen HU, Glaesmer H, Marz W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Bohler S, Pittrow D, Ruf G (2005) Cardiovascular risk factors in primary care: methods and baseline prevalence rates - the DETECT program. Curr Med Res Opin 21(4):619-630. doi: 10.1185/030079905X38187
-
(2005)
Curr Med Res Opin
, vol.21
, Issue.4
, pp. 619-630
-
-
Wittchen, H.U.1
Glaesmer, H.2
Marz, W.3
Stalla, G.4
Lehnert, H.5
Zeiher, A.M.6
Silber, S.7
Koch, U.8
Bohler, S.9
Pittrow, D.10
Ruf, G.11
-
16
-
-
0037118660
-
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee
-
12119259 10.1161/01.CIR.0000020190.45892.75
-
Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA, Goldstein LB, Goldstein LB, Greenland P, Grundy SM, Hong Y, Miller NH, Lauer RM, Ockene IS, Sacco RL, Sallis JF Jr, Smith SC Jr, Stone NJ, Taubert KA (2002) AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 106(3):388-391
-
(2002)
Circulation
, vol.106
, Issue.3
, pp. 388-391
-
-
Pearson, T.A.1
Blair, S.N.2
Daniels, S.R.3
Eckel, R.H.4
Fair, J.M.5
Fortmann, S.P.6
Franklin, B.A.7
Goldstein, L.B.8
Goldstein, L.B.9
Greenland, P.10
Grundy, S.M.11
Hong, Y.12
Miller, N.H.13
Lauer, R.M.14
Ockene, I.S.15
Sacco, R.L.16
Sallis Jr., J.F.17
Smith Jr., S.C.18
Stone, N.J.19
Taubert, K.A.20
more..
-
17
-
-
0037126526
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
-
National Cholesterol Education Program (NCEP)
-
National Cholesterol Education Program (NCEP) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106(25):3143-3421
-
(2002)
Circulation
, vol.106
, Issue.25
, pp. 3143-3421
-
-
-
18
-
-
0012431804
-
Report of the expert committee on the diagnosis and classification of diabetes mellitus
-
American Diabetes Association
-
American Diabetes Association (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5-20
-
(2003)
Diabetes Care
, vol.26
, Issue.SUPPL. 1
, pp. 5-20
-
-
-
19
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators
-
10.1056/NEJM200001203420301 10639539 10.1056/NEJM200001203420301 1:STN:280:DC%2BD3c%2Fpt1emug%3D%3D
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators. N Engl J Med 342(3):145-153. doi: 10.1056/NEJM200001203420301
-
(2000)
N Engl J Med
, vol.342
, Issue.3
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
20
-
-
70350458768
-
A novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology
-
10.1186/1471-2288-9-63 19744332 10.1186/1471-2288-9-63
-
Klotsche J, Ferger D, Pieper L, Rehm J, Wittchen HU (2009) A novel nonparametric approach for estimating cut-offs in continuous risk indicators with application to diabetes epidemiology. BMC Med Res Methodol 9:63. doi: 10.1186/1471-2288-9-63
-
(2009)
BMC Med Res Methodol
, vol.9
, pp. 63
-
-
Klotsche, J.1
Ferger, D.2
Pieper, L.3
Rehm, J.4
Wittchen, H.U.5
-
21
-
-
38849091997
-
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
-
10.1002/sim.2929 17569110 10.1002/sim.2929 discussion 207-112
-
Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27(2):157-172. doi: 10.1002/sim.2929 discussion 207-112
-
(2008)
Stat Med
, vol.27
, Issue.2
, pp. 157-172
-
-
Pencina, M.J.1
D'Agostino, Sr.R.B.2
D'Agostino Jr., R.B.3
Vasan, R.S.4
-
22
-
-
84944363874
-
Evaluating the yield of medical tests
-
7069920 10.1001/jama.1982.03320430047030
-
Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. JAMA 247(18):2543-2546
-
(1982)
JAMA
, vol.247
, Issue.18
, pp. 2543-2546
-
-
Harrell Jr., F.E.1
Califf, R.M.2
Pryor, D.B.3
Lee, K.L.4
Rosati, R.A.5
-
23
-
-
3242770671
-
Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation
-
10.1002/sim.1802 15211606 10.1002/sim.1802
-
Pencina MJ, D'Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med 23(13):2109-2123. doi: 10.1002/sim.1802
-
(2004)
Stat Med
, vol.23
, Issue.13
, pp. 2109-2123
-
-
Pencina, M.J.1
D'Agostino, R.B.2
-
24
-
-
1442290043
-
Plasma natriuretic peptide levels and the risk of cardiovascular events and death
-
10.1056/NEJMoa031994 14960742 10.1056/NEJMoa031994 1:CAS:528: DC%2BD2cXhtFCrtrg%3D
-
Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004) Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350(7):655-663. doi: 10.1056/NEJMoa031994
-
(2004)
N Engl J Med
, vol.350
, Issue.7
, pp. 655-663
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
Benjamin, E.J.4
Leip, E.P.5
Omland, T.6
Wolf, P.A.7
Vasan, R.S.8
-
25
-
-
0032568486
-
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
-
9610529 10.1161/01.CIR.97.20.2007 1:STN:280:DyaK1c3nt1Slsg%3D%3D
-
Ridker PM, Glynn RJ, Hennekens CH (1998) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97(20):2007-2011
-
(1998)
Circulation
, vol.97
, Issue.20
, pp. 2007-2011
-
-
Ridker, P.M.1
Glynn, R.J.2
Hennekens, C.H.3
-
26
-
-
0035680020
-
The Malmo Diet and Cancer Study: Representativity, cancer incidence and mortality in participants and non-participants
-
11916347 10.1097/00008469-200112000-00003 1:STN:280: DC%2BD387ot1Gisw%3D%3D
-
Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G (2001) The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev 10(6):489-499
-
(2001)
Eur J Cancer Prev
, vol.10
, Issue.6
, pp. 489-499
-
-
Manjer, J.1
Carlsson, S.2
Elmstahl, S.3
Gullberg, B.4
Janzon, L.5
Lindstrom, M.6
Mattisson, I.7
Berglund, G.8
-
27
-
-
34548425213
-
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
-
10.1093/eurheartj/ehl448 17242007 10.1093/eurheartj/ehl448 1:CAS:528:DC%2BD2sXot1agt7s%3D
-
Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR (2007) N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J 28(11):1374-1381. doi: 10.1093/eurheartj/ehl448
-
(2007)
Eur Heart J
, vol.28
, Issue.11
, pp. 1374-1381
-
-
Olsen, M.H.1
Hansen, T.W.2
Christensen, M.K.3
Gustafsson, F.4
Rasmussen, S.5
Wachtell, K.6
Ibsen, H.7
Torp-Pedersen, C.8
Hildebrandt, P.R.9
-
28
-
-
79959499350
-
N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease
-
10.1016/j.jacc.2011.02.041 21700090 10.1016/j.jacc.2011.02.041 1:CAS:528:DC%2BC3MXps1yisbc%3D
-
Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, Rumley A, Whincup PH, Sattar N (2011) N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. J Am Coll Cardiol 58(1):56-64. doi: 10.1016/j.jacc.2011.02.041
-
(2011)
J Am Coll Cardiol
, vol.58
, Issue.1
, pp. 56-64
-
-
Wannamethee, S.G.1
Welsh, P.2
Lowe, G.D.3
Gudnason, V.4
Di Angelantonio, E.5
Lennon, L.6
Rumley, A.7
Whincup, P.H.8
Sattar, N.9
-
29
-
-
84876503104
-
-
http://www.theheart.org/article/1242883.do
-
-
-
-
30
-
-
33747079319
-
Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study
-
10.1161/CIRCULATIONAHA.105.590927 16831981 10.1161/CIRCULATIONAHA.105. 590927 1:CAS:528:DC%2BD28Xms1yrtLo%3D
-
Blankenberg S, McQueen MJ, Smieja M, Pogue J, Balion C, Lonn E, Rupprecht HJ, Bickel C, Tiret L, Cambien F, Gerstein H, Munzel T, Yusuf S (2006) Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 114(3):201-208. doi: 10.1161/CIRCULATIONAHA.105.590927
-
(2006)
Circulation
, vol.114
, Issue.3
, pp. 201-208
-
-
Blankenberg, S.1
McQueen, M.J.2
Smieja, M.3
Pogue, J.4
Balion, C.5
Lonn, E.6
Rupprecht, H.J.7
Bickel, C.8
Tiret, L.9
Cambien, F.10
Gerstein, H.11
Munzel, T.12
Yusuf, S.13
-
31
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
10.1056/NEJMoa0807646 18997196 10.1056/NEJMoa0807646 1:CAS:528: DC%2BD1cXhtl2gurnL
-
Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195-2207. doi: 10.1056/NEJMoa0807646
-
(2008)
N Engl J Med
, vol.359
, Issue.21
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
Genest, J.4
Gotto Jr., A.M.5
Kastelein, J.J.6
Koenig, W.7
Libby, P.8
Lorenzatti, A.J.9
Macfadyen, J.G.10
Nordestgaard, B.G.11
Shepherd, J.12
Willerson, J.T.13
Glynn, R.J.14
-
32
-
-
81255161677
-
Biomarkers: Optimizing treatment guidance in heart failure
-
10.1007/s00392-011-0341-0 21779815 10.1007/s00392-011-0341-0
-
Bohm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100(11):973-981. doi: 10.1007/s00392-011-0341-0
-
(2011)
Clin Res Cardiol
, vol.100
, Issue.11
, pp. 973-981
-
-
Bohm, M.1
Voors, A.A.2
Ketelslegers, J.M.3
Schirmer, S.H.4
Turgonyi, E.5
Bramlage, P.6
Zannad, F.7
-
33
-
-
77951625683
-
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
-
10.1016/j.jacc.2010.01.031 20447539 10.1016/j.jacc.2010.01.031 1:CAS:528:DC%2BC3cXnvVahtL8%3D
-
McKie PM, Cataliotti A, Lahr BD, Martin FL, Redfield MM, Bailey KR, Rodeheffer RJ, Burnett JC Jr (2010) The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects. J Am Coll Cardiol 55(19):2140-2147. doi: 10.1016/j.jacc.2010.01.031
-
(2010)
J Am Coll Cardiol
, vol.55
, Issue.19
, pp. 2140-2147
-
-
McKie, P.M.1
Cataliotti, A.2
Lahr, B.D.3
Martin, F.L.4
Redfield, M.M.5
Bailey, K.R.6
Rodeheffer, R.J.7
Burnett Jr., J.C.8
-
34
-
-
21344475107
-
The changing face of cardiovascular risk
-
10.1016/j.jacc.2005.05.007 15992653 10.1016/j.jacc.2005.05.007
-
Grundy SM (2005) The changing face of cardiovascular risk. J Am Coll Cardiol 46(1):173-175. doi: 10.1016/j.jacc.2005.05.007
-
(2005)
J Am Coll Cardiol
, vol.46
, Issue.1
, pp. 173-175
-
-
Grundy, S.M.1
-
35
-
-
33845882230
-
The cardiovascular disease continuum validated: Clinical evidence of improved patient outcomes: Part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions
-
10.1161/CIRCULATIONAHA.106.655761 17179035 10.1161/CIRCULATIONAHA.106. 655761
-
Dzau VJ, Antman EM, Black HR, Hayes DL, Manson JE, Plutzky J, Popma JJ, Stevenson W (2006) The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 114(25):2871-2891. doi: 10.1161/CIRCULATIONAHA.106.655761
-
(2006)
Circulation
, vol.114
, Issue.25
, pp. 2871-2891
-
-
Dzau, V.J.1
Antman, E.M.2
Black, H.R.3
Hayes, D.L.4
Manson, J.E.5
Plutzky, J.6
Popma, J.J.7
Stevenson, W.8
|